2021 Q1 Form 10-K Financial Statement

#000107023521000029 Filed on March 31, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2021 2020 Q1
Revenue $210.0M $893.0M $282.0M
YoY Change -25.53% -14.13% 10.59%
Cost Of Revenue $58.00M $250.0M $70.00M
YoY Change -17.14% -9.75% 45.83%
Gross Profit $152.0M $643.0M $212.0M
YoY Change -28.3% -15.73% 2.42%
Gross Profit Margin 72.38% 72.0% 75.18%
Selling, General & Admin $95.00M $344.0M $115.0M
YoY Change -17.39% -30.22% 9.52%
% of Gross Profit 62.5% 53.5% 54.25%
Research & Development $45.00M $215.0M $57.00M
YoY Change -21.05% -16.99% 9.62%
% of Gross Profit 29.61% 33.44% 26.89%
Depreciation & Amortization $49.00M $198.0M $52.00M
YoY Change -5.77% -6.6% 57.58%
% of Gross Profit 32.24% 30.79% 24.53%
Operating Expenses $443.0M $1.750B $225.0M
YoY Change 96.89% 91.89% 23.63%
Operating Profit -$291.0M -$1.107B -$13.00M
YoY Change 2138.46% 642.95% -152.0%
Interest Expense $0.00 -$7.000M $0.00
YoY Change -800.0% -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$313.0M -$1.113B -$42.00M
YoY Change 645.24% 652.03% -231.25%
Income Tax $2.000M -$9.000M -$1.000M
% Of Pretax Income
Net Earnings -$315.0M -$1.104B -$41.00M
YoY Change 668.29% 626.32% -180.39%
Net Earnings / Revenue -150.0% -123.63% -14.54%
Basic Earnings Per Share -$1.97
Diluted Earnings Per Share -$556.5K -$1.97 -$73.65K
COMMON SHARES
Basic Shares Outstanding 565.5M shares 561.3M shares 554.2M shares
Diluted Shares Outstanding 561.3M shares

Balance Sheet

Concept 2021 Q1 2021 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $739.0M $739.0M $909.0M
YoY Change -18.7% -18.7% -0.76%
Cash & Equivalents $214.0M $214.0M $377.0M
Short-Term Investments $525.0M $525.0M $532.0M
Other Short-Term Assets $50.00M $50.00M $52.00M
YoY Change -3.85% -3.85% -7.14%
Inventory
Prepaid Expenses
Receivables $182.0M $182.0M $215.0M
Other Receivables $35.00M $35.00M $20.00M
Total Short-Term Assets $1.006B $1.006B $1.196B
YoY Change -15.89% -15.89% -3.0%
LONG-TERM ASSETS
Property, Plant & Equipment $48.00M $111.0M $70.00M
YoY Change -31.43% -42.78% -17.65%
Goodwill $849.0M $1.437B
YoY Change -40.92% -1.78%
Intangibles
YoY Change
Long-Term Investments $37.00M $37.00M $32.00M
YoY Change 15.63% 15.63% -41.82%
Other Assets $16.00M $44.00M $65.00M
YoY Change -75.38% -61.4% 132.14%
Total Long-Term Assets $1.812B $1.812B $2.692B
YoY Change -32.69% -32.69% -1.57%
TOTAL ASSETS
Total Short-Term Assets $1.006B $1.006B $1.196B
Total Long-Term Assets $1.812B $1.812B $2.692B
Total Assets $2.818B $2.818B $3.888B
YoY Change -27.52% -27.52% -2.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.00M $20.00M $31.00M
YoY Change -35.48% -35.48% -35.42%
Accrued Expenses $178.0M $178.0M $202.0M
YoY Change -11.88% -11.44% 5.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $607.0M
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $429.0M $429.0M $1.121B
YoY Change -61.73% -61.73% 119.8%
LONG-TERM LIABILITIES
Long-Term Debt $720.0M $720.0M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $6.000M $165.0M $9.000M
YoY Change -33.33% -30.67% -52.63%
Total Long-Term Liabilities $6.000M $885.0M $9.000M
YoY Change -33.33% 271.85% -52.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $429.0M $429.0M $1.121B
Total Long-Term Liabilities $6.000M $885.0M $9.000M
Total Liabilities $1.314B $1.314B $1.359B
YoY Change -3.31% -3.31% 2.03%
SHAREHOLDERS EQUITY
Retained Earnings -$1.306B -$198.0M
YoY Change 559.6% 518.75%
Common Stock $2.823B $2.760B
YoY Change 2.28% 2.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.504B $1.504B $2.529B
YoY Change
Total Liabilities & Shareholders Equity $2.818B $2.818B $3.888B
YoY Change -27.52% -27.52% -2.02%

Cashflow Statement

Concept 2021 Q1 2021 2020 Q1
OPERATING ACTIVITIES
Net Income -$315.0M -$1.104B -$41.00M
YoY Change 668.29% 626.32% -180.39%
Depreciation, Depletion And Amortization $49.00M $198.0M $52.00M
YoY Change -5.77% -6.6% 57.58%
Cash From Operating Activities $52.00M $82.00M $34.00M
YoY Change 52.94% 215.38% 88.89%
INVESTING ACTIVITIES
Capital Expenditures -$16.00M $8.000M -$11.00M
YoY Change 45.45% -33.33% 0.0%
Acquisitions
YoY Change
Other Investing Activities -$101.0M -$21.00M -$145.0M
YoY Change -30.34% -85.42% -72.9%
Cash From Investing Activities -$117.0M -$65.00M -$156.0M
YoY Change -25.0% -65.43% -71.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $19.00M
YoY Change -311.11%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.000M -$227.0M 1.000M
YoY Change 800.0% -3342.86%
NET CHANGE
Cash From Operating Activities 52.00M $82.00M 34.00M
Cash From Investing Activities -117.0M -$65.00M -156.0M
Cash From Financing Activities 9.000M -$227.0M 1.000M
Net Change In Cash -56.00M -$208.0M -121.0M
YoY Change -53.72% 33.33% -77.08%
FREE CASH FLOW
Cash From Operating Activities $52.00M $82.00M $34.00M
Capital Expenditures -$16.00M $8.000M -$11.00M
Free Cash Flow $68.00M $74.00M $45.00M
YoY Change 51.11% 428.57% 55.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-02-28
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001070235
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
565505328 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
554199016 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
565505328 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
554199016 shares
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10000000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9000000 USD
CY2021 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
0 USD
CY2020 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
0 USD
CY2019 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
0 USD
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax
0 USD
CY2020 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax
0 USD
CY2019 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax
0 USD
CY2021 bbry Term Subscription Contract Duration
TermSubscriptionContractDuration
P4Y
CY2021 bbry Software Maintenance Revenue Term Io T
SoftwareMaintenanceRevenueTermIoT
P1Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2021 bbry Share Based Compensation Arrangement By Share Based Payment Award Other Than Stock Options Award Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanStockOptionsAwardVestingPeriod
P3Y
CY2021Q1 bbry Number Of Endpoints Secured
NumberOfEndpointsSecured
500000000 endpoint
CY2021Q1 bbry Number Of Endpoints Secured Cars
NumberOfEndpointsSecuredCars
175000000 endpoint
CY2021 bbry Amount Of Options That Will Vest On Monthly Basis After Year1
AmountOfOptionsThatWillVestOnMonthlyBasisAfterYear1
0.75 shares
CY2021 bbry Tbrsu Share Limit
TBRSUShareLimit
1 shares
CY2021 bbry Pbrsu Share Limit
PBRSUShareLimit
1.5 shares
CY2021 bbry Cews First Extension Date Of Program
CEWSFirstExtensionDateOfProgram
2020-12-19
CY2021 bbry Cews Second Extension Date Of Program
CEWSSecondExtensionDateOfProgram
2021-06-01
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-02-28
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-38232
CY2021 dei Entity Registrant Name
EntityRegistrantName
BlackBerry Limited
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0164408
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
2200 University Ave East
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Waterloo
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
CY2021 dei Entity Address Country
EntityAddressCountry
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
N2K 0A7
CY2021 dei City Area Code
CityAreaCode
(519)
CY2021 dei Local Phone Number
LocalPhoneNumber
888-7465
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Public Float
EntityPublicFloat
2900000000 USD
CY2020Q3 dei Entity Public Float
EntityPublicFloat
2900000000 USD
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
565542886 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
214000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
377000000 USD
CY2021Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
525000000 USD
CY2020Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
532000000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
182000000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
215000000 USD
CY2021Q1 us-gaap Other Receivables
OtherReceivables
25000000 USD
CY2020Q1 us-gaap Other Receivables
OtherReceivables
14000000 USD
CY2021Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
10000000 USD
CY2020Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
6000000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
50000000 USD
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
52000000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
1006000000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
1196000000 USD
CY2021Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
28000000 USD
CY2020Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
49000000 USD
CY2021Q1 us-gaap Long Term Investments
LongTermInvestments
37000000 USD
CY2020Q1 us-gaap Long Term Investments
LongTermInvestments
32000000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16000000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
65000000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
63000000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
124000000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
70000000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
849000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
1437000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
771000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
915000000 USD
CY2021Q1 us-gaap Assets
Assets
2818000000 USD
CY2020Q1 us-gaap Assets
Assets
3888000000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
20000000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
31000000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
178000000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
202000000 USD
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
6000000 USD
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
18000000 USD
CY2021Q1 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
0 USD
CY2020Q1 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
606000000 USD
CY2021Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
225000000 USD
CY2020Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
264000000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
429000000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1121000000 USD
CY2021Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
69000000 USD
CY2020Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
109000000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90000000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
120000000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6000000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9000000 USD
CY2021Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
720000000 USD
CY2020Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
0 USD
CY2021Q1 us-gaap Liabilities
Liabilities
1314000000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
1359000000 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
2823000000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
2760000000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1306000000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-198000000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13000000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33000000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1504000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
2529000000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2818000000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3888000000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
2505000000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
93000000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4000000 USD
CY2019 bbry Cumulative Impact Asu606 Adoption
CumulativeImpactASU606Adoption
-86000000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
67000000 USD
CY2019 bbry Precombinationserviceofreplacementawardsincludedinpurchaseconsideration Se
PrecombinationserviceofreplacementawardsincludedinpurchaseconsiderationSE
21000000 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000000 USD
CY2019 bbry Exchangesharesrelatedtobusinesscombination
Exchangesharesrelatedtobusinesscombination
35000000 USD
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4000000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
2636000000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-152000000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-13000000 USD
CY2020 bbry Cumulative Impact Asc842 Adoption
CumulativeImpactASC842Adoption
-14000000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
63000000 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000000 USD
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
2529000000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1104000000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
20000000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44000000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000000 USD
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
7000000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1504000000 USD
CY2021 us-gaap Revenues
Revenues
893000000 USD
CY2020 us-gaap Revenues
Revenues
1040000000 USD
CY2019 us-gaap Revenues
Revenues
904000000 USD
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
250000000 USD
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
277000000 USD
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
206000000 USD
CY2021 us-gaap Gross Profit
GrossProfit
643000000 USD
CY2020 us-gaap Gross Profit
GrossProfit
763000000 USD
CY2019 us-gaap Gross Profit
GrossProfit
698000000 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
215000000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
259000000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
219000000 USD
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
344000000 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
493000000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
409000000 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
182000000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
194000000 USD
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
136000000 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
594000000 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
22000000 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
43000000 USD
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
10000000 USD
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-372000000 USD
CY2020 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
66000000 USD
CY2019 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
117000000 USD
CY2021 bbry Arbitration Awards And Settlements Net Included In Operations
ArbitrationAwardsAndSettlementsNetIncludedInOperations
0 USD
CY2020 bbry Arbitration Awards And Settlements Net Included In Operations
ArbitrationAwardsAndSettlementsNetIncludedInOperations
0 USD
CY2019 bbry Arbitration Awards And Settlements Net Included In Operations
ArbitrationAwardsAndSettlementsNetIncludedInOperations
-9000000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
1750000000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
912000000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
638000000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1107000000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-149000000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
60000000 USD
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
-6000000 USD
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
1000000 USD
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
17000000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1113000000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-148000000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
77000000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9000000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16000000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1104000000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-152000000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
93000000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.97
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.97
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1104000000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-152000000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
93000000 USD
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2000000 USD
CY2019 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1000000 USD
CY2021 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
2000000 USD
CY2020 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-1000000 USD
CY2019 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
1000000 USD
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5000000 USD
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000000 USD
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000000 USD
CY2021 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
13000000 USD
CY2020 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
-7000000 USD
CY2019 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
0 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
20000000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1084000000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-165000000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
89000000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1104000000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-152000000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
93000000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
198000000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
212000000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
149000000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3000000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-25000000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
44000000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
63000000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
67000000 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
594000000 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
22000000 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
43000000 USD
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
10000000 USD
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2021 bbry Noncashconsiderationreceivedfromcontractswithcustomers
Noncashconsiderationreceivedfromcontractswithcustomers
0 USD
CY2020 bbry Noncashconsiderationreceivedfromcontractswithcustomers
Noncashconsiderationreceivedfromcontractswithcustomers
-8000000 USD
CY2019 bbry Noncashconsiderationreceivedfromcontractswithcustomers
Noncashconsiderationreceivedfromcontractswithcustomers
-46000000 USD
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-372000000 USD
CY2020 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
66000000 USD
CY2019 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
117000000 USD
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3000000 USD
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2000000 USD
CY2019 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-12000000 USD
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1402000000 USD
CY2021 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
24000000 USD
CY2020 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0 USD
CY2020 bbry Change In Consideration For Business Acquisition
ChangeInConsiderationForBusinessAcquisition
1000000 USD
CY2019 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0 USD
CY2021 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1039000000 USD
CY2020 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1180000000 USD
CY2019 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
2895000000 USD
CY2021 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1047000000 USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1017000000 USD
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
35000000 USD
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1000000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11000000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-17000000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15000000 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-20000000 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-15000000 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-21000000 USD
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-15000000 USD
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1000000 USD
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2000000 USD
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-79000000 USD
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-18000000 USD
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-36000000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
82000000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26000000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
100000000 USD
CY2021 bbry Payments To Acquire Long Term Marketable Securities And Other Investments
PaymentsToAcquireLongTermMarketableSecuritiesAndOtherInvestments
5000000 USD
CY2020 bbry Payments To Acquire Long Term Marketable Securities And Other Investments
PaymentsToAcquireLongTermMarketableSecuritiesAndOtherInvestments
1000000 USD
CY2019 bbry Payments To Acquire Long Term Marketable Securities And Other Investments
PaymentsToAcquireLongTermMarketableSecuritiesAndOtherInvestments
2000000 USD
CY2021 bbry Proceeds From Sale And Maturity Of Long Term Marketable Securities And Other Investments
ProceedsFromSaleAndMaturityOfLongTermMarketableSecuritiesAndOtherInvestments
0 USD
CY2020 bbry Proceeds From Sale And Maturity Of Long Term Marketable Securities And Other Investments
ProceedsFromSaleAndMaturityOfLongTermMarketableSecuritiesAndOtherInvestments
19000000 USD
CY2019 bbry Proceeds From Sale And Maturity Of Long Term Marketable Securities And Other Investments
ProceedsFromSaleAndMaturityOfLongTermMarketableSecuritiesAndOtherInvestments
2000000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000000 USD
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000000 USD
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
36000000 USD
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
32000000 USD
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
32000000 USD
CY2021 bbry Change In Consideration For Business Acquisition
ChangeInConsiderationForBusinessAcquisition
0 USD
CY2019 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3970000000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-65000000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-188000000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-375000000 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
19000000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9000000 USD
CY2021 bbry Operating Lease Cash Flow
OperatingLeaseCashFlow
4000000 USD
CY2020 bbry Operating Lease Cash Flow
OperatingLeaseCashFlow
9000000 USD
CY2019 bbry Operating Lease Cash Flow
OperatingLeaseCashFlow
0 USD
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000000 USD
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-10000000 USD
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6000000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29000000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18000000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9000000 USD
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
11000000 USD
CY2020 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-5000000 USD
CY2019 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-52000000 USD
CY2021 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
4000000 USD
CY2020 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-3000000 USD
CY2019 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-17000000 USD
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-55000000 USD
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000000 USD
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1000000 USD
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2000000 USD
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 USD
CY2021 us-gaap Repayments Of Debt
RepaymentsOfDebt
610000000 USD
CY2020 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
CY2019 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
365000000 USD
CY2020 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2019 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-227000000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7000000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5000000 USD
CY2021 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2000000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1000000 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3000000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-208000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
582000000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-156000000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-273000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
426000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
582000000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
855000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
426000000 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements requires management to make estimates and assumptions with respect to the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities. Significant areas requiring the use of management estimates relate to revenue-related estimates including variable consideration, standalone selling price (“SSP”), estimated customer life, if control of licenses to intellectual property has transferred, the value of non-cash consideration, right of return and customer incentive commitments, fair value of reporting units in relation to actual or potential goodwill impairment, fair value of the Debentures (as defined in Note 7), fair value of share-based liability award, fair value of long-lived assets in relation to actual or potential impairment, the Company’s long-lived asset groupings, useful lives of property, plant and equipment and intangible assets, provision for income taxes, realization of deferred income tax assets and the related components of the valuation allowance, allowance for credit losses, incremental borrowing rate in determining the present value of lease liabilities and the determination of reserves for various litigation claims. Actual results could differ from these estimates, which were based upon circumstances that existed as of the date of the consolidated financial statements, February 28, 2021. Subsequent to this date, it is reasonably possible that the COVID-19 pandemic and its impact on the health of the global economy could cause changes to estimates as a result of the financial circumstances of the markets in which the Company operates and the price of the Company’s publicly traded equity in comparison to the Company’s carrying value.</span></div>
CY2021 bbry Liability For Uncertain Tax Positions Percentage Minimum
LiabilityForUncertainTaxPositionsPercentageMinimum
0.50
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
45875000 shares
CY2021 bbry Shares Issuedas Options Number Counted
SharesIssuedasOptionsNumberCounted
0.625 shares
CY2021 bbry Options Forfeited Numberof Shares Counted
OptionsForfeitedNumberofSharesCounted
0.625 shares
CY2021 bbry Rs Usforfeitedsettledincashorsoldtocoverwithholdingtaxrequirementscountedas
RSUsforfeitedsettledincashorsoldtocoverwithholdingtaxrequirementscountedas
1 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
18000000 shares
CY2019Q1 bbry Black Berry Cylance Plan Authorized Numberofshares
BlackBerryCylancePlanAuthorizedNumberofshares
9144176 shares
CY2021 bbry Options To Vest In Year1
OptionsToVestInYear1
0.25 shares
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
13000000 USD
CY2021 bbry Investments That Are Communicated To Third Party For Consideration Of Reasonableness Threshold Limit For Fair Value
InvestmentsThatAreCommunicatedToThirdPartyForConsiderationOfReasonablenessThresholdLimitForFairValue
0.005
CY2020 bbry Gain On Sale Of Auction Rate Securities
GainOnSaleOfAuctionRateSecurities
3000000 USD
CY2019 bbry Gain On Sale Of Auction Rate Securities
GainOnSaleOfAuctionRateSecurities
0 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
594000000 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
22000000 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021 bbry Impairment Of Long Lived Assets Held For Use Gross
ImpairmentOfLongLivedAssetsHeldForUseGross
46000000 USD
CY2021 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
37000000 USD
CY2021 bbry Impact Of Revaluation Of Certain Lease Liabilites
ImpactOfRevaluationOfCertainLeaseLiabilites
3000000 USD
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
10000000 USD
CY2020 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
8000000 USD
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2021Q1 bbry Cash Cash Equivalents And Investments At Cost
CashCashEquivalentsAndInvestmentsAtCost
811000000 USD
CY2021 bbry Cash Cash Equivalents And Investments Unrealized Gains
CashCashEquivalentsAndInvestmentsUnrealizedGains
0 USD
CY2021 bbry Cash Cash Equivalents And Investments Unrealized Losses
CashCashEquivalentsAndInvestmentsUnrealizedLosses
7000000 USD
CY2021Q1 bbry Cash Cash Equivalents And Investments At Fair Value
CashCashEquivalentsAndInvestmentsAtFairValue
804000000 USD
CY2021Q1 bbry Cashandcashequivalent
Cashandcashequivalent
214000000 USD
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
525000000 USD
CY2021Q1 us-gaap Long Term Investments
LongTermInvestments
37000000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4000000 USD
CY2021Q1 us-gaap Restricted Investments
RestrictedInvestments
24000000 USD
CY2020Q1 bbry Cash Cash Equivalents And Investments At Cost
CashCashEquivalentsAndInvestmentsAtCost
998000000 USD
CY2020 bbry Cash Cash Equivalents And Investments Unrealized Gains
CashCashEquivalentsAndInvestmentsUnrealizedGains
0 USD
CY2020 bbry Cash Cash Equivalents And Investments Unrealized Losses
CashCashEquivalentsAndInvestmentsUnrealizedLosses
-8000000 USD
CY2020Q1 bbry Cash Cash Equivalents And Investments At Fair Value
CashCashEquivalentsAndInvestmentsAtFairValue
990000000 USD
CY2020Q1 bbry Cashandcashequivalent
Cashandcashequivalent
377000000 USD
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
532000000 USD
CY2020Q1 us-gaap Long Term Investments
LongTermInvestments
32000000 USD
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
34000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
426000000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
49000000 USD
CY2021Q1 bbry Equity Investmentwithout Readily Determinable Fair Value
EquityInvestmentwithoutReadilyDeterminableFairValue
37000000 USD
CY2020Q1 bbry Equity Investmentwithout Readily Determinable Fair Value
EquityInvestmentwithoutReadilyDeterminableFairValue
32000000 USD
CY2021 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 USD
CY2020 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
3000000 USD
CY2019 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 USD
CY2021 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0 USD
CY2019 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0 USD
CY2020 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
214000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
377000000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
548000000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4000000 USD
CY2020Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
49000000 USD
CY2021Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
7000000 USD
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
8000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
582000000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
599000000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
599000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
856000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
856000000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
10000000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
3000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
10000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
2000000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
609000000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
602000000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
866000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
858000000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9000000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9000000 USD
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-3000000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10000000 USD
CY2021Q1 bbry Accounts Receivable Allowance For Credit Loss Relating To Cecl Estimated Based On Days Past Due And Region
AccountsReceivableAllowanceForCreditLossRelatingToCECLEstimatedBasedOnDaysPastDueAndRegion
3000000 USD
CY2021Q1 bbry Accounts Receivable Allowance For Credit Loss Relating To Customers Evaluated Separately
AccountsReceivableAllowanceForCreditLossRelatingToCustomersEvaluatedSeparately
7000000 USD
CY2021Q1 bbry Numberof Customers Witha Balance Greaterthan10of Total Accounts Receivable
NumberofCustomersWithaBalanceGreaterthan10ofTotalAccountsReceivable
1
CY2020Q1 bbry Numberof Customers Witha Balance Greaterthan10of Total Accounts Receivable
NumberofCustomersWithaBalanceGreaterthan10ofTotalAccountsReceivable
2
CY2021 bbry Other Current Assets Greaterthanfivepercentof Current Assets
OtherCurrentAssetsGreaterthanfivepercentofCurrentAssets
0 other_current_asset
CY2020 bbry Other Current Assets Greaterthanfivepercentof Current Assets
OtherCurrentAssetsGreaterthanfivepercentofCurrentAssets
0 other_current_asset
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
259000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
240000000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
211000000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
170000000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
70000000 USD
CY2021 us-gaap Depreciation
Depreciation
21000000 USD
CY2020 us-gaap Depreciation
Depreciation
24000000 USD
CY2019 us-gaap Depreciation
Depreciation
20000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2015000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1244000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
771000000 USD
CY2021 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
36000000 USD
CY2020 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
32000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2002000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
153000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
117000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1087000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
915000000 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
177000000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
188000000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
129000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
109000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
101000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
95000000 USD
CY2018Q1 us-gaap Goodwill
Goodwill
569000000 USD
CY2019 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-5000000 USD
CY2019 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
899000000 USD
CY2019Q1 us-gaap Goodwill
Goodwill
1463000000 USD
CY2020 us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustments Related To Previous Period
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
2000000 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
22000000 USD
CY2020 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-2000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
1437000000 USD
CY2021 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
6000000 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
594000000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
849000000 USD
CY2021 bbry Other Long Term Assets Greater Than Five Percent Of Total Assets
OtherLongTermAssetsGreaterThanFivePercentOfTotalAssets
0 USD
CY2020 bbry Other Long Term Assets Greater Than Five Percent Of Total Assets
OtherLongTermAssetsGreaterThanFivePercentOfTotalAssets
0 USD
CY2019Q1 bbry Business Acquisition Purchase Priceof Acquired Entity
BusinessAcquisitionPurchasePriceofAcquiredEntity
1400000000 USD
CY2019 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
12000000 USD
CY2020 us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustments Related To Previous Period
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
2000000 USD
CY2021Q1 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
16000000 USD
CY2020Q1 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
33000000 USD
CY2021Q1 bbry Operating Lease Liabilities Current Included In Accruals
OperatingLeaseLiabilitiesCurrentIncludedInAccruals
33000000 USD
CY2020Q1 bbry Operating Lease Liabilities Current Included In Accruals
OperatingLeaseLiabilitiesCurrentIncludedInAccruals
31000000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
129000000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
138000000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
178000000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
202000000 USD
CY2021 bbry Other Accrued Liabilities Greaterthan Five Percentof Current Liabilities
OtherAccruedLiabilitiesGreaterthanFivePercentofCurrentLiabilities
0 USD
CY2020 bbry Other Accrued Liabilities Greaterthan Five Percentof Current Liabilities
OtherAccruedLiabilitiesGreaterthanFivePercentofCurrentLiabilities
0 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-295000000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-39000000 USD
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
20000000 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
205000000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
41000000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-55000000 USD
CY2021 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
41000000 USD
CY2020 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
10000000 USD
CY2019 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
10000000 USD
CY2021 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-48000000 USD
CY2020 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-12000000 USD
CY2019 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
9000000 USD
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
3000000 USD
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-4000000 USD
CY2020 bbry Difference In Income Taxes Resulting From Goodwill Impairment
DifferenceInIncomeTaxesResultingFromGoodwillImpairment
6000000 USD
CY2019 bbry Difference In Income Taxes Resulting From Goodwill Impairment
DifferenceInIncomeTaxesResultingFromGoodwillImpairment
0 USD
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
3000000 USD
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-1000000 USD
CY2021 bbry Nondeductiblepermanentdifference
Nondeductiblepermanentdifference
13000000 USD
CY2020 bbry Nondeductiblepermanentdifference
Nondeductiblepermanentdifference
15000000 USD
CY2019 bbry Nondeductiblepermanentdifference
Nondeductiblepermanentdifference
19000000 USD
CY2021 bbry Difference In Income Taxes Resulting From Goodwill Impairment
DifferenceInIncomeTaxesResultingFromGoodwillImpairment
158000000 USD
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1000000 USD
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
2000000 USD
CY2021 bbry Effective Income Tax Rate Reconciliation Withholding Taxon Unremitted Earningsamounts
EffectiveIncomeTaxRateReconciliationWithholdingTaxonUnremittedEarningsamounts
0 USD
CY2020 bbry Effective Income Tax Rate Reconciliation Withholding Taxon Unremitted Earningsamounts
EffectiveIncomeTaxRateReconciliationWithholdingTaxonUnremittedEarningsamounts
-1000000 USD
CY2019 bbry Effective Income Tax Rate Reconciliation Withholding Taxon Unremitted Earningsamounts
EffectiveIncomeTaxRateReconciliationWithholdingTaxonUnremittedEarningsamounts
0 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9000000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16000000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-383000000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
15000000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
63000000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-730000000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-163000000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
14000000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1113000000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-148000000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
77000000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-2000000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2000000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
59000000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2000000 USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-7000000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
3000000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
7000000 USD
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-1000000 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-25000000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9000000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16000000 USD
CY2021Q1 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
240000000 USD
CY2020Q1 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
174000000 USD
CY2020Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
65000000 USD
CY2021Q1 bbry Minimum Taxes
MinimumTaxes
206000000 USD
CY2020Q1 bbry Minimum Taxes
MinimumTaxes
267000000 USD
CY2021Q1 bbry Deferred Tax Assets Convertible Debentures
DeferredTaxAssetsConvertibleDebentures
94000000 USD
CY2020Q1 bbry Deferred Tax Assets Convertible Debentures
DeferredTaxAssetsConvertibleDebentures
1000000 USD
CY2021Q1 bbry Deferred Tax Assets Researchand Development
DeferredTaxAssetsResearchandDevelopment
390000000 USD
CY2020Q1 bbry Deferred Tax Assets Researchand Development
DeferredTaxAssetsResearchandDevelopment
327000000 USD
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
414000000 USD
CY2020Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
419000000 USD
CY2021Q1 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
82000000 USD
CY2020Q1 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
117000000 USD
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1485000000 USD
CY2020Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1370000000 USD
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1360000000 USD
CY2020Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1223000000 USD
CY2021Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
125000000 USD
CY2020Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
147000000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
147000000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 USD
CY2020Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
72000000 USD
CY2019Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
84000000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
125000000 USD
CY2020Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
147000000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
125000000 USD
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
205000000 USD
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
41000000 USD
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1360000000 USD
CY2020Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1223000000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
24000000 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
72000000 USD
CY2018Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
73000000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2000000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
10000000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2000000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1000000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
5000000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
50000000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
15000000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
4000000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
24000000 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
72000000 USD
CY2019Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
84000000 USD
CY2021Q1 bbry Unrecognizedtaxbenefitsnettedagainstdeferredincometaxes
Unrecognizedtaxbenefitsnettedagainstdeferredincometaxes
22000000 USD
CY2021Q1 bbry Unrecognizedtaxbenefitsincludedwithintaxespayable
Unrecognizedtaxbenefitsincludedwithintaxespayable
2000000 USD
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1104000000 USD
CY2020 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-152000000 USD
CY2021 bbry Debentures Fair Value Impact On Diluted Eps
DebenturesFairValueImpactOnDilutedEPS
0 USD
CY2020 bbry Debentures Fair Value Impact On Diluted Eps
DebenturesFairValueImpactOnDilutedEPS
66000000 USD
CY2019 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
93000000 USD
CY2019 bbry Debentures Fair Value Impact On Diluted Eps
DebenturesFairValueImpactOnDilutedEPS
117000000 USD
CY2021 bbry Interest Expense Debt On Diluted Eps
InterestExpenseDebtOnDilutedEPS
0 USD
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
23000000 USD
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
24000000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1104000000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-195000000 USD
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
0 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
561305000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
553861000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
540477000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
11308000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2021Q1 us-gaap Increase In Unrecognized Tax Benefits Is Reasonably Possible
IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
0 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
3000000 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
4000000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0 USD
CY2021Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1539000000 USD
CY2021Q1 bbry Capital Loss Carryforward
CapitalLossCarryforward
19000000 USD
CY2021Q1 bbry Researchanddevelopmenttaxcredit
Researchanddevelopmenttaxcredit
473000000 USD
CY2021Q1 bbry Minimum Taxes
MinimumTaxes
206000000 USD
CY2021Q1 bbry Par Value Repurchase Percentage Changeof Control
ParValueRepurchasePercentageChangeofControl
1.15
CY2021Q1 bbry Ownership Percentageby Arms Length Party Common Shares
OwnershipPercentagebyArmsLengthPartyCommonShares
0.35
CY2021Q1 bbry Ownership Percentage Common Shares
OwnershipPercentageCommonShares
0.50
CY2020 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
60500000 shares
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
15000000 USD
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
23000000 USD
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
24000000 USD
CY2021 us-gaap Debt Instrument Frequency Of Periodic Payment
DebtInstrumentFrequencyOfPeriodicPayment
quarterly
CY2021 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
2000000 USD
CY2021 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
60800000 shares
CY2019 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
60500000 shares
CY2021 bbry Incrementalcommonsharesattributabletoexchangeshare
Incrementalcommonsharesattributabletoexchangeshare
0 shares
CY2020 bbry Incrementalcommonsharesattributabletoexchangeshare
Incrementalcommonsharesattributabletoexchangeshare
0 shares
CY2019 bbry Incrementalcommonsharesattributabletoexchangeshare
Incrementalcommonsharesattributabletoexchangeshare
4182000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
561305000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
614361000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
616467000 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.97
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.97
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021Q1 bbry Number Of Exchanges Shares Remaining To Be Issued
NumberOfExchangesSharesRemainingToBeIssued
1421945 shares
CY2020Q1 bbry Number Of Exchanges Shares Remaining To Be Issued
NumberOfExchangesSharesRemainingToBeIssued
2802067 shares
CY2019Q1 bbry Fairvalueofreplacementawards
Fairvalueofreplacementawards
39000000 USD
CY2019Q1 bbry Precombinationserviceofreplacementawardsincludedinpurchaseconsideration
Precombinationserviceofreplacementawardsincludedinpurchaseconsideration
21000000 USD
CY2019Q1 bbry Postcombinationserviceofreplacementawards
Postcombinationserviceofreplacementawards
18000000 USD
CY2021Q1 bbry Postcombinationserviceofreplacementawardsunrecognizedexpense
Postcombinationserviceofreplacementawardsunrecognizedexpense
3000000 USD
CY2020Q1 bbry Postcombinationserviceofreplacementawardsunrecognizedexpense
Postcombinationserviceofreplacementawardsunrecognizedexpense
6000000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5705000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.41
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3072000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.78
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1050000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.51
CY2019 bbry Asu20161 Adoptionchangeinfairvalueequitysecuritiestoinvestmentincome
ASU20161Adoptionchangeinfairvalueequitysecuritiestoinvestmentincome
8000000 USD
CY2019 bbry Adoption20161 Changeinfairvalueofdebenturefrominstrumentspecificcreditrisk
Adoption20161Changeinfairvalueofdebenturefrominstrumentspecificcreditrisk
-14000000 USD
CY2021Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
28000000 USD
CY2021Q1 bbry Funds From Claim Filed With Ministry Of Innovation Science And Economic Development Canada Relating To Strategic Innovation Fund Program
FundsFromClaimFiledWithMinistryOfInnovationScienceAndEconomicDevelopmentCanadaRelatingToStrategicInnovationFundProgram
15000000 USD
CY2020Q1 bbry Funds From Claim Filed With Ministry Of Innovation Science And Economic Development Canada Relating To Strategic Innovation Fund Program
FundsFromClaimFiledWithMinistryOfInnovationScienceAndEconomicDevelopmentCanadaRelatingToStrategicInnovationFundProgram
10000000 USD
CY2021Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2021 us-gaap Lessor Operating Lease Option To Terminate
LessorOperatingLeaseOptionToTerminate
three months
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
30000000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
33000000 USD
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1000000 USD
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2000000 USD
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 USD
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 USD
CY2021 bbry Finance Lease Cost
FinanceLeaseCost
1000000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1583000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.92
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M23D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8000000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1475000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.85
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y4M24D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
8000000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1035000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.40
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M8D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6000000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2.22 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4.30 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2.55 USD
CY2020 bbry Finance Lease Cost
FinanceLeaseCost
2000000 USD
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
861290 shares
CY2021 us-gaap Restricted Stock Expense
RestrictedStockExpense
1000000 USD
CY2020 us-gaap Restricted Stock Expense
RestrictedStockExpense
3000000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2023-11-03
CY2019 bbry Equity Award Number Of Vesting Tranches
EquityAwardNumberOfVestingTranches
5 tranche
CY2019 bbry Equity Award Number Of Vesting Tranches
EquityAwardNumberOfVestingTranches
5 tranche
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
37000000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
40000000 USD
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1000000 USD
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2000000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4000000 USD
CY2021 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
4000000 USD
CY2021 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
37000000 USD
CY2021 us-gaap Sublease Income
SubleaseIncome
1000000 USD
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1000000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1000000 USD
CY2020 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1000000 USD
CY2020 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1000000 USD
CY2020 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
8000000 USD
CY2020 us-gaap Sublease Income
SubleaseIncome
2000000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
63000000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
124000000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90000000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
120000000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
123000000 USD
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
151000000 USD
CY2021Q1 bbry Finance Lease Right Of Use Asset Cost
FinanceLeaseRightOfUseAssetCost
3000000 USD
CY2020Q1 bbry Finance Lease Right Of Use Asset Cost
FinanceLeaseRightOfUseAssetCost
5000000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
3000000 USD
CY2020Q1 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
4000000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 USD
CY2020Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1000000 USD
CY2020Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1000000 USD
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 USD
CY2020Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 USD
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
0 USD
CY2020Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
1000000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y8M12D
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M
CY2021Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M24D
CY2020Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.034
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.036
CY2021Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.025
CY2020Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.022
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
36000000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
0 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
30000000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
0 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
22000000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
0 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
17000000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
12000000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
16000000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
133000000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
0 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10000000 USD
CY2021Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
0 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
123000000 USD
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
0 USD
CY2021 us-gaap Revenues
Revenues
893000000 USD
CY2021 bbry Percentage Of Revenue Attributable To Major Geographic Segments
PercentageOfRevenueAttributableToMajorGeographicSegments
1.000
CY2020 us-gaap Revenues
Revenues
1040000000 USD
CY2020 bbry Percentage Of Revenue Attributable To Major Geographic Segments
PercentageOfRevenueAttributableToMajorGeographicSegments
1.000
CY2019 us-gaap Revenues
Revenues
904000000 USD
CY2019 bbry Percentage Of Revenue Attributable To Major Geographic Segments
PercentageOfRevenueAttributableToMajorGeographicSegments
1.000
CY2021 us-gaap Revenues
Revenues
893000000 USD
CY2020 us-gaap Revenues
Revenues
1040000000 USD
CY2019 us-gaap Revenues
Revenues
904000000 USD
CY2021 us-gaap Revenues
Revenues
893000000 USD
CY2020 us-gaap Revenues
Revenues
1040000000 USD
CY2019 us-gaap Revenues
Revenues
904000000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
324000000 USD
CY2021 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
2000000 USD
CY2020 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1000000 USD
CY2019 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
11000000 USD
CY2021Q1 us-gaap Noncurrent Assets
NoncurrentAssets
1731000000 USD
CY2021Q1 us-gaap Assets
Assets
2818000000 USD
CY2020Q1 us-gaap Noncurrent Assets
NoncurrentAssets
2546000000 USD
CY2020Q1 us-gaap Assets
Assets
3888000000 USD
CY2021 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
one
CY2020 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
one
CY2019 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
one
CY2021 us-gaap Interest Paid Net
InterestPaidNet
15000000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
23000000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
24000000 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5000000 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8000000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6000000 USD
CY2021 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
2000000 USD
CY2020 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
9000000 USD
CY2019 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
15000000 USD
CY2021 us-gaap Advertising Expense
AdvertisingExpense
24000000 USD
CY2020 us-gaap Advertising Expense
AdvertisingExpense
39000000 USD
CY2019 us-gaap Advertising Expense
AdvertisingExpense
22000000 USD
CY2021 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1000000 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
0 USD
CY2019 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-2000000 USD
CY2021Q1 bbry Percentage Of Cash And Cash Equivalents Denominated In Foreign Currencies
PercentageOfCashAndCashEquivalentsDenominatedInForeignCurrencies
0.20
CY2021Q1 bbry Percentage Of Accounts Receivable Denominated In Foreign Currencies
PercentageOfAccountsReceivableDenominatedInForeignCurrencies
0.25
CY2021Q1 bbry Percentage Of Accrued Liabilities Denominated In Foreign Currencies
PercentageOfAccruedLiabilitiesDenominatedInForeignCurrencies
0.34
CY2020Q1 bbry Percentage Of Cash And Cash Equivalents Denominated In Foreign Currencies
PercentageOfCashAndCashEquivalentsDenominatedInForeignCurrencies
0.12
CY2020Q1 bbry Percentage Of Accounts Receivable Denominated In Foreign Currencies
PercentageOfAccountsReceivableDenominatedInForeignCurrencies
0.17
CY2020Q1 bbry Percentage Of Accrued Liabilities Denominated In Foreign Currencies
PercentageOfAccruedLiabilitiesDenominatedInForeignCurrencies
0.17
CY2021 bbry Percent Of Cash Equivalents And Investments Threshold Used To Determine Major Issuers
PercentOfCashEquivalentsAndInvestmentsThresholdUsedToDetermineMajorIssuers
0.13
CY2020 bbry Percent Of Cash Equivalents And Investments Threshold Used To Determine Major Issuers
PercentOfCashEquivalentsAndInvestmentsThresholdUsedToDetermineMajorIssuers
0.08
CY2021Q1 us-gaap Derivative Asset Fair Value Of Collateral
DerivativeAssetFairValueOfCollateral
0 USD
CY2020Q1 us-gaap Derivative Asset Fair Value Of Collateral
DerivativeAssetFairValueOfCollateral
1000000 USD
CY2021Q1 bbry Cash Cash Equivalents And Investments At Fair Value
CashCashEquivalentsAndInvestmentsAtFairValue
804000000 USD
CY2021 bbry Cews Subsidy Of Eligible Employees Employee Insurable Remuneration
CEWSSubsidyOfEligibleEmployeesEmployeeInsurableRemuneration
0.75
CY2021Q1 bbry Cews Subsidy Of Eligible Employees Employee Insurable Remuneration After Extension Dec2020 To June2021
CEWSSubsidyOfEligibleEmployeesEmployeeInsurableRemunerationAfterExtensionDec2020ToJune2021
0.65
CY2021 bbry Cews Subsidy Of Eligible Employees Employee Insurable Remuneration
CEWSSubsidyOfEligibleEmployeesEmployeeInsurableRemuneration
0.75
CY2021 bbry Government Subsidies
GovernmentSubsidies
53000000 USD

Files In Submission

Name View Source Status
0001070235-21-000029-index-headers.html Edgar Link pending
0001070235-21-000029-index.html Edgar Link pending
0001070235-21-000029.txt Edgar Link pending
0001070235-21-000029-xbrl.zip Edgar Link pending
a21-bbxconsentletterfina.htm Edgar Link pending
a21-bbxconsentletterfina001.jpg Edgar Link pending
bb-02282021x10kexhibit231.htm Edgar Link pending
bb-02282021x10kexhibit311.htm Edgar Link pending
bb-02282021x10kexhibit312.htm Edgar Link pending
bb-02282021x10kexhibit321.htm Edgar Link pending
bb-02282021x10kexhibit322.htm Edgar Link pending
bbry-20210228.htm Edgar Link pending
bbry-20210228.xsd Edgar Link pending
bbry-20210228_cal.xml Edgar Link unprocessable
bbry-20210228_def.xml Edgar Link unprocessable
bbry-20210228_g1.jpg Edgar Link pending
bbry-20210228_htm.xml Edgar Link completed
bbry-20210228_lab.xml Edgar Link unprocessable
bbry-20210228_pre.xml Edgar Link unprocessable
exhibit21-bbsubsidiariesfe.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending